Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study

Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study

Background: The present study aimed to examine the odds of cholangiocarcinoma (CCA) in patients with proton pump inhibitors (PPIs) use.Methods: A nested case-control study design was employed using data obtained from Taiwan's National Health Insurance Research Database. In total, 2,293 patients...

Full description

Bibliographic Details
Main Authors: Yen-Chun Peng, Cheng-Li Lin, Wan-Yun Hsu, Wai-Keung Chow, Show-Wu Lee, Hong-Zen Yeh, Chia-Chang Chen, Chia-Hung Kao
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-07-01
Series:Frontiers in Pharmacology
Subjects:
cholangiocarcinoma
proton pump inhibitors
case-control study
defined daily dose
odds ratios
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.00718/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2018.00718/full

Similar Items